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A total of 30 Pasteurella multocida strains isolated from 333 pneumonic and
apparently health slaughter cattle were examined for capsule biosynthesis genes and
23 virulence-associated genes by polymerase chain reaction (PCR). The disc diffusion
technique was used to determine antimicrobial resistance profiles among the isolates. Of
the isolates, 23 belonged to capsular type A, 5 to capsular type D and two isolates were
untypeable. The distribution of the capsular types in pneumonic lungs and in apparently
health lungs was statistically similar. All virulence genes tested were detected among the
isolates derived from pneumonic lungs; whereas isolates derived from apparently health
lungs carried 16 of the 23 genes. The frequently detected genes among isolates from
pneumonic lungs were exbD, hgbA, hgbB, ompA, ompH, oma87, and sodC; whereas
tadD, toxA, and pmHAS genes occurred less frequently. Most of the adhesins and
superoxide dismutases; and all of the iron acquisition and protectin proteins occurred
at significantly (p ≤ 0.05) higher frequencies in isolates from pneumonic lungs. Isolates
from apparently healthy lungs didn’t carry the following genes; hsf-1, hsf-2, tadD, toxA,
nanB, nanH, and pmHAS. One adhesion (hsf-1) and two iron acquisition (exbD and tonB)
genes occurred at significantly (p ≤ 0.05) higher frequencies among capA isolates. All
the P. multocida isolates were susceptible to ciprofloxacin, co-trimoxazole, doxycycline,
enrofloxacin, nitrofurantoin, and tetracyclines. Different proportions of the isolates were
however resistant to ampicillin, amoxicillin, erythromycin, lincomycin, penicillin, rifampin,
streptomycin, and florfenicol. Our results reveal presence of virulence factors (VFs)
in P. multocida strains isolated from symptomatic and asymptomatic bovids. A higher
frequency of the factors among isolates from symptomatic study animals may suggest
their role in pathogenesis of P. multocida-associated bovine respiratory disease (BRD). The
results further reveal occurrence of antimicrobial resistance among some isolates. Control
strategies for this pathogen, which could include development of an effective vaccine, are
warranted so as to mitigate the social and economic consequences attributable to natural
infections with this bacterium.
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INTRODUCTION
Cattle rearing is one of the important sources of income in Iran,
involving both dairy and beef breeds. The sector faces a number
of constraints ranging from limited feed resources to diseases. Of
the diseases, those caused by infectious agents are of great impor-
tance which include bacteria and viruses affecting the respiratory
system (Hemmatzadeh et al., 2001; Haji Hajikolaei and Seyfi Abad
Shapouri, 2007; Sakhaee et al., 2009). The most important bacte-
ria that play a role in pneumonia include:Mannheimia haemolyt-
ica, Pasteurella multocida, and Haemophilus somnus pneumonia,
which presence of these bacteria in pneumonia lesions of slaugh-
tered cattle around Iran have also been reported (Haji Hajikolaei
et al., 2010).
Bovine respiratory disease (BRD) is a significant cause of mor-
bidity and mortality among beef cattle in the world (Dagleish
et al., 2010; Hotchkiss et al., 2010; Portis et al., 2012). Among
others, Pasteurella multocida has been identified as a major
bacterial etiologic agent for this disease (Confer, 2009; Griffin
et al., 2010). It is a zoonotic Gram negative bacterium respon-
sible for a range of infections in domestic animals causing
substantial economic losses (Steen et al., 2010). The organism
causes fowl cholera in domestic and wild birds, bronchop-
neumonia and hemorrhagic septicemia in bovids, atrophic
rhinitis in porcines and snuffles in rabbits (Mannheim, 1984;
Hunt et al., 2000). Most human infections with P. multo-
cida result from dog and cat bites, but infections through
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the respiratory tract may also occur (Hubbert and Rosen,
1970).
Several host and pathogen-specific attributes do determine the
outcome of infections caused by P. multocida (Verma et al., 2013).
Of the pathogen factors important ones include the capsular
and virulence-associated genes (Katsuda et al., 2013). These viru-
lence factors (VFs) and outer membrane proteins are important
for pathogenesis, functionality, protective immunity and vaccine
development against P. multocida infections (Harper et al., 2006;
Hatfaludi et al., 2010). Based on capsular antigens, P. multocida
strains are differentiated into five serogroups i.e., type A causing
fowl cholera pathogen and bovine shipping fever, type B causing
hemorrhagic fever in ungulates, type D causing atrophic rhinitis
in swine, type E, an African serotype, infecting cattle and buffalo;
and type F also causing fowl cholera (Carter, 1955, 1961, 1967;
Rimler and Rhoades, 1987). Virulence associated genes described
for P. multocida isolates and their examples include adherence and
colonization factors (ptfA, fimA, hsf-1, hsf-2, pfhA, and tadD),
iron-regulated and acquisition proteins(exbB, exbD, tonB, hgbA,
hgbB, and Fur), extracellular enzymes such as neuraminidase
(nanB and nanH), hyaluronidase (pmHAS) and superoxide dis-
mutases (soda, sodC, and tbpA), toxins (toxA), lipopolysaccha-
rides (LPS), capsule and a variety of outer membrane proteins
such as protectins (ompA, omph, oma87, and plpB) (Katoch et al.,
2014).
Increased use of antibiotics in modern animal production has
been associated with emergence of antimicrobial resistant bac-
teria with potential for transfer of resistance from animals to
humans (Witte, 1998). As a result, antimicrobial resistance among
bacterial pathogens has of recent become a big problem in both
the veterinary and human medicine fields (Levy, 1998; Caprioli
et al., 2000; Kehrenberg et al., 2001; White et al., 2002; Shea,
2003). The implication of the problem is increased treatment cost,
prolonged illness due to treatment failure and sometimes death
(Kelly et al., 2004).
The present study was conducted with the aim to detect the
occurrence of VFs in P. multocida isolated from pneumonic and
apparently health lungs of slaughter cattle in Iran. It was also to
determine the occurrence of antimicrobial resistance among the
isolates.
MATERIALS AND METHODS
SAMPLE COLLECTION
A total of 333 samples, from both pneumonic (219) and appar-
ently healthy (114) lungs, were collected randomly from slaughter
cattle in an industrial abattoir in Shahrekord province during the
period of September 2013 to March 2014. The abattoir receives
cattle from different herds within and outside the province. For
the purpose of this study pneumonic lungs referred to those lungs
with gross lesions such as consolidation, fibrin deposition on the
pleura, pleurisy, and/or adhesion; and apparently healthy lungs
was used to describe those lungs without gross lesions. A simple
random procedure was used to select pre-identified pneumonic
and apparently health lungs. Random numbers were generated
in Microsoft excel®. Specimens were obtained aseptically using a
sterile scalpel while taking precautions to prevent surface contam-
ination. Following collection the samples were conveyed to the
microbiology laboratory in special ice-filled containers within 6 h
of sampling.
P. MULTOCIDA SCREENING
Isolation of P. multocidawas done using techniques described pre-
viously by other authors (Songer and Post, 2005). Briefly, swabs
were obtained from the collected samples and were plated on
tryptic soy agar (Difco, Detroit, MI) containing 10µg/ml NAD
(Sigma, St. Louis, MO) and 5% bovine serum, MacConkey agar,
and blood agar (5% fresh sheep blood). All plates were incubated
at 37◦C in air for a minimum of 48 h.
IDENTIFICATION OF ISOLATES
Preliminary identification of P. multocida isolates was carried
out according to standard biochemical tests as described ear-
lier (Songer and Post, 2005). The isolates were gram-negative
coccobacilli and were indole, catalase and oxidase-positive. But,
citrate, Methyl red (MR), Vogaes–Proskauer (VP), and gelatin liq-
uefaction negative. They don’t grow on MacConkey agar and do
not show hemolysis on blood agar. Confirmation of the isolates
was done by polymerase chain reaction (PCR) assay with primers
specific for the amplification of the KMT1 gene, adopting the
methodology previously described by Townsend et al. (1998). All
confirmed isolates of P. multocida were subsequently character-
ized by capsular serotyping using PCR. Primers for amplification
of hyaD-hyaC and DcbF genes were used for detection of capsular
type A and capsular type D, respectively (Table 1). P. multocida
isolates which didn’t yield bands on PCR when the two primers
were used were classified as untyped. Following confirmation and
characterization all isolates were freeze-dried and kept at −20◦C.
DETECTION OF VIRULENCE GENES
The virulence genes of P. multocida isolates were detected by PCR.
They included adhesins (ptfA, fimA, hsf-1, hsf-2, pfhA, and tadD),
Table 1 | Primers used for the detection of serogroups in strains of P. multocida.
Serogroup Gene Primer
name
Primer sequence (5′–3′) Amplic size (bp) Anneal. Temp (◦C) Reference
All KMT1 KMT1T7
KMT1SP6
ATCCGCTATTTACCCAGTGG
GCTGTAAACGAACTCGCCAC
460 55 Townsend et al., 1998
Capsular type A hyaD-hyaC CAPA-F
CAPA-R
CATTTATCCAAGCTCCACC
GCCCGAGAGTTTCAATCC
760 55
Capsular type D DcbF CAPD-F
CAPD-R
TTACAAAAGAAAGACTAGGAGCCC
CATCTACCCACTCAACCATATCAG
657 55
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toxin (toxA), iron acquisition (exbB, exbD, tonB, hgbA, hgbB,
and Fur), sialidases (nanB and nanH), hyaluronidase (pmHAS),
protectins (ompA, omph, oma87, and plpB) and superoxide dis-
mutases (soda, sodC, and tbpA) (Table 2). The base sequences
and the predicted sizes of the amplified products for the spe-
cific oligonucleotide primers used in detection of the genes in
this study are shown in Table 3. The bacterial lysates used as tem-
plates for the PCR were prepared as follows. A loopful of bacteria
from a fresh overnight culture on a tryptic soy agar plate was
resuspended homogeneously in 200µl of sterile water, and the
mixture was boiled at 100◦C for 5min to release the DNA and
centrifuged. A 4µl volume of the supernatant was used as a tem-
plate for each 25µl PCR mixture. The amplified products were
analyzed in 1% agarose gels by electrophoresis, and the results
were recorded with a gel documentation system. All tests were
repeated three times in parallel with the relevant positive (P. mul-
tocida strains ATCC 15742, ATCC 12945, and ATCC 12946) and
negative (distilled water) controls. Discrepant results for each VF
Table 2 | Tested virulence-associated genes in strains of P. multocida.
Gene function and gene Description
ADHESINS
ptfA Type 4 fimbriae
fimA Fimbriae (from Pm70)
hsf-1 Autotransporter adhesion (from Pm70)
hsf-2 Autotransporter adhesion (from Pm70)
pfhA Filamentous hemagglutinin
tadD Putative non-specific tight adherence protein D
toxA Dermonecrotic toxin
exbB Accessory protein Ton-dependent transport of
iron compounds
exbD Accessory protein Ton-dependent transport of
iron compound
tonB Iron transporters, transport ferric-siderophore
complexes
hgbA A hemoglobin-binding protein
hgbB B hemoglobin-iron uptake
Fur Ferric uptake regulation protein
SIALIDASES nanB
nanB Outer membrane-associated proteins, an
autotransporter protein
nanH Outer membrane-associated proteins, small
sialidases
HYALURONIDASE
pmHAS Hyaluronan synthase
SUPEROXIDE DISMUTASE
sodA Superoxide dismutase
sodC Superoxide dismutase
tbpA Superoxide dismutase
PROTECTINS
ompA Outer membrane protein A
ompH Outer membrane protein H
oma87 Outer membrane protein 87
plpB Lipoprotein B
were investigated further, and samples were sequenced for gene
verification.
ANTIMICROBIAL RESISTANCE TEST
Antimicrobial resistance profiles of the isolates to 20 antimicro-
bial agents were determined by the disc diffusion method on
Muller Hinton agar with 5% blood (Carter and Subronto, 1978).
The plates were inoculated with a cotton swab dipped into a
0.5 McFarland standard suspension of each isolates, according
to the procedures outline in NCCLS (NCCLS, 2008). Then, the
plates were incubated at 37◦C for 24 h. The inhibition zones
around each disc were measured and interpretation of results
made according to the guidelines provided by manufacturers
(Pattan-Teb, Tehran, Iran) and those provided by NCCLS (2008).
The results were interpreted as resistant (R), intermediate (I), and
susceptible (S).
STATISTICAL DATA ANALYSIS
Data analysis was performed in SPSS software version 12.0 (SPSS
Inc., Chicago, IL). Descriptive statistics were computed to deter-
mine the proportions of the different VFs among the isolates;
and proportions of isolates resistant to different antimicrobial
agents. Chi square test adopted for determination of statistical
significance of differences between the proportions.
RESULTS
PREVALENCE OF P. MULTOCIDA IN COLLECTED SAMPLES
The prevalence of P. multocida in collected lung samples is indi-
cated in Table 4. Overall 9.0% (30/333) of the sampled cattle
were infected with the organism. The frequency of infection with
the organism was higher in pneumonic lungs than in appar-
ently health lungs and the difference was statistically significant
at p ≤ 0.05.
DISTRIBUTION OF VFs ACCORDING TO CAPSULAR SEROTYPES
Two capsular types (A and D) were detected among 28 of the 30
isolates obtained as seen in Tables 5, 6. The majority (76.7%) of
the isolates were of capsular type A. The distribution of the cap-
sular types in pneumonic lungs and in apparently health lungs
(Table 5) didn’t show any statistically significant difference. The
distribution of capsular serotypes for each individual isolate is
displayed in Table 6.
DISTRIBUTION OF VFs ACCORDING TO ASSOCIATED VF GENES
All isolates from pneumonic lungs harbored at least one vir-
ulence gene as displayed in Table 7. Table 8 shows the distri-
bution of virulence genes by capsular serotypes. The detected
virulence genes for each isolate obtained in this study is
presented in Table 6. Most of the adhesins and superox-
ide dismutases; and all of the iron acquisition and protectin
proteins occurred at significantly (p ≤ 0.05) higher frequen-
cies in isolates from pneumonic lungs. One adhesion (hsf-1)
and two iron acquisition (exbD and tonB) genes occurred
at significantly (p ≤ 0.05) higher frequencies among capA
isolates.
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Table 3 | Primers used for the detection of virulence-associated genes in strains of P. multocida.
Gene function and gene Primer sequence (5′–3′) Amplicon size (bp) Annealing temp (◦C) References
ADHESINS
ptfA TGTGGAATTCAGCATTTTAGTGTGTC
TCATGAATTCTTATGCGCAAAATCCT
GCTGG
488 55 Townsend et al., 1998
fimA CCATCGGATCTAAACGACCTA
AGTATTAGTTCCTGCGGGTG
866 55
hsf-1 TTGAGTCGGCTGTAGAGTTCG
ACTCTTTAGCAGTGGGGACAACCTC
654 54
hsf-2 ACCGCAACCATGCTCTTAC
TGACTGACATCGGCGGTAC
433 54
pfhA TTCAGAGGGATCAATCTTCG
AACTCCAGT TGGTTTGTCG
286 55
tadD TCTACCCATTCTCAGCAAGGC
ATCATTTCGGGCATTCACC
416 55
TOXINS
toxA CTTAGATGAGCGACAAGG
GAATGCCACACCTCTATAG
864 55 Townsend et al., 1998
SUPEROXIDE DISMUTASE
sodA TACCAGAATTAGGCTACGC
GAAACGGGTTGCTGCCGCT
361 55 Ewers et al., 2006
tbpA TTGGTTGGAAACGGTAAAGC
TAACGTGTACGGAAAAGCCC
728 54
sodC AGTTAGTAGCGGGGTTGGCA
TGGTGCTGGGTGATCATCATG
235 55 Lainson et al., 1996
SIALIDASES nanB
nanB CATTGCACCTAACACCTCT
GGACACTGATTGCCCTGAA
555 55 Townsend et al., 1998
nanH GTGGGAACGGGAATTGTGA
ACATGCCAAGTTTGCCCTA
287 55
PROTECTINS
ompA CGCATAGCACTCAAGTTTCTCC
CATAAACAGATTGACCGAAACG
201 55 Townsend et al., 1998
ompH CGCGTATGAAGGTTTAGGT
TTTAGATTGTGCGTAGTCAAC
438 55
oma87 GGCAGCGAGCAACAGATAACG
TGTTCGTCAAATGTCGGGTGA
838 55
plpB TTTGGTGGTGCGTATGTCTTCT
AGTCACTTTAGATTGTGCGTAG
282 55
HYALURONIDASE
pmHAS TCAATGTTTGCGATAGTCCGTTAG
TGGCGAATGATCGGTGATAGA
430 54 Townsend et al., 1998
IRON ACQUISITION
exbB TTGGCTTGTGATTGAACGC
TGCAGGAATGGCGACTAA A
283 55 Townsend et al., 1998
exbD CGTTCTGATTACAGCCTCTT
AACGAAATCTTGGAAACTGG
247 55
tonB CGACGGTGAAACCTGAGCCA
CCGAGCGATAAGCATTGACT
261 55
hgbA TCAACGGCAGATAATCAGGG
GCGGGAATGCTGAAGATAAG
267 55
Fur GTTTACCGTGTATTAGACCA
CATTACTACATTTGCCATAC
244 55
hgbB ACCGCGTTGGAATTATGATTG
CATTGAGTACGGCTTGACAT
788 55 Ewers et al., 2006
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Table 4 | Prevalence of P. multocida in collected cattle lung samples.
Lung samples Number of samples Number of positive samples
Pneumonic lungs 219 25 (11.4%)
Healthy lungs 114 5 (4.4%)
Total 333 30 (9.0%)
Table 5 | Distribution of capsular serotypes among the isolates.
Capsular Overall Pneumonic lung Apparently healthy
types prevalence isolates lung isolates
(n = 30) (n = 25) (n = 5)
Type A 23 (76.7%) 18 (72.0%) 5 (100.0%)
Type D 5 (16.7%) 5 (20.0%) –
Untyped 2 (6.7%) 2 (8.0%) –
ANTIMICROBIAL RESISTANCE AMONG THE ISOLATES
Antimicrobial resistance profiles of P. multocida isolates obtained
in this study are displayed in Table 9. All the isolates were suscep-
tible to ciprofloxacin, co-trimoxazole, doxycycline, enrofloxacin,
nitrofurantoin, and tetracyclines. Resistance to ampicillin, lin-
comycin, penicillin, rifampin, streptomycin, amoxicillin, ery-
thromycin, and florfenicol was observed at different frequencies.
DISCUSSION
VFs play a key role in disease production by bacterial pathogens
(Nanduri et al., 2009). Among others, their functions include
competence, adherence, synthesis, and export of capsules; and
evasion of host immune responses (Nanduri et al., 2009). In the
present study the factors have been detected in P. multocida iso-
lated from the lungs of slaughter cattle. The higher frequency of
the factors among isolates from pneumonic lungs suggests the
role of these factors in disease occurrence. It was pointed out that
virulence gene occurrence in P. multocida has a strong positive
association with the outcome of infection with the organism in
cattle (Katsuda et al., 2013). On the other hand occurrence of the
factors in apparently healthy lungs could possibly indicate early
infection or contained infection which couldn’t lead to disease. It
was previously reported that this facultative anaerobic bacterium
is commonly found in clinically healthy calves (Lainson et al.,
2013).
In this study capsular types A and D were detected using PCR
among the obtained P. multocida isolates. A small proportion
(6.7%; 2/30) of P. multocida strains were untypeable, a similar
observation to what was reported by Arumugam et al. (2011).
Capsular type A was predominant among the strains account-
ing for 76.6%. Our observation is similar to a finding by Katsuda
et al. (2013) who also detected capsular types A and D among cat-
tle derived P. multocida isolates; with type A occurring at higher
frequency. A higher frequency of capsular type A among cattle
derived P. multocida isolates has also been reported in a study con-
ducted earlier by Davies et al. (2004) who found that 99.3% of
bovine P. multocida strains (n = 153) were of this capsular type.
P. multocida isolates of serotype A are common in bovids occur-
ring as normal flora in the nasopharynx; or as causes of disease
including BRD and hemorraghic septicemia (Ewers et al., 2004;
Dabo et al., 2007). The capsular type A is also most frequently
described for rabbits (Ewers et al., 2006) and pigs (García et al.,
2011).
Of the protectins; OmpA and oma87 were the most frequently
detected genes particularly in the isolates from pneumonic lungs.
Slightly higher frequencies of the two genes were noted for iso-
lates of the capA serogroup than those belonging to the capD
serogroup. The OmpA gene has a significant role in stabilizing
the cell envelope structure by providing physical linkage between
the outer membrane and peptidoglycan (Katoch et al., 2014).
It mediates P. multocida host cells interaction through heparin
and/or fibronectin binding and thus acts as an important invasive
molecule which could determine the outcome of infection with
the organism (Katoch et al., 2014).
The type 4 fimbria (ptfA gene) was described in 92.0% of
the isolates tested in the current study. The gene plays a key
role of fixing bacterial pathogens on the surface of the epithelial
cells of hosts, a phenomenon which is more common in rabbits
(Ewers et al., 2006). Consequently a study conducted on rabbits
described a high prevalence of the ptfA gene (93.4%; 43/46).
Presence of adhesins on the bacterial surface is usually linked
to virulence as these proteins are known to play a crucial role
in facilitating host invasion and colonization (Kline et al., 2009).
Studies by Ewers et al. (2000) and Tang et al. (2009) have demon-
strated that, of the adhesins; fimA, hsf-2, and ptfA are of frequent
occurrence among pathogenic isolates of P. multocida. In the
current study the three adhesins were demonstrated at higher fre-
quencies than others in both capA and capD serogroup isolates.
On the other hand, gene tadD was the least frequently detected
adhesin among P. multocida, occurring only in 48.0% of the iso-
lates (n = 30). In these organisms the gene is known to be a
putative non-specific tight adherence protein D (May et al., 2001).
A more or less similar low frequency (43.3%; 100/233) of tadD
was described in a field study involving pigs (Tang et al., 2009).
A work on rabbits, however, observed a higher frequency (91.3%;
42/46) of this gene among P. multocida strains.
It is noteworthy that the dermonecrotoxin encoding toxA was
the least frequently detected gene among the isolates; demon-
strated only in those of capsular type A obtained from pneumonic
lungs. Some other researchers indicated that this particular gene
is more frequently expressed by strains of serogroup D and is
responsible for the clinical symptoms associated with atrophic
rhinitis in porcines (Harper et al., 2006; Ferreira et al., 2012).
The observation in the current study could be attributed to the
small sample size of capsular type D isolates. In a study con-
ducted earlier the gene was detected in P. multocida isolates
from avians, swine, shoats and cattle; but was only associated
with disease in pigs (Ewers et al., 2006). Pullinger et al. (2004)
points out that the toxA gene is not inserted into the bacterial
chromosome but in a lysogenic bacteriophage that infects the
agent.
The tbpA encoding gene is known to be of common occurrence
among ruminant P. multocida strains (Ewers et al., 2006; Atashpaz
et al., 2009). Its prevalence was however relatively low when com-
pared to other superoxide dismutases (sodA and sodC) tested in
this study. Ferreira et al. (2012) found a low frequency (8.6%;
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Table 6 | Capsular types and virulence genes detected among
P. multocida isolates obtained from cattle lungs in Iran.
Strain ID Capsule type Virulence genes
1 Type A ptfA, fimA, hsf-1, tonB, hgbA, hgbB, Fur,
nanB, nanH, pmHAS, ompA, oomph, plpB,
soda, sodC
2 Type A ptfA, fimA, hsf-1, exbD, tonB, hgbA, hgbB,
Fur, nanB, nanH, pmHAS, ompA, oomph,
oma87, plpB, soda, sodC
3 Type A ptfA, fimA, hsf-1, tonB, hgbA, hgbB, Fur,
nanB, nanH, pmHAS, ompA, oomph, oma87,
plpB, soda, sodC, tbpA
4 Type D ptfA, hsf-2, pfhA, exbB, exbD, hgbA, hgbB,
Fur, nanB, nanH, ompA, oomph, oma87,
plpB, sodC, tbpA
5 Type D ptfA, fimA, hsf-2, pfhA, tadD, exbB, hgbA,
hgbB, Fur, nanB, nanH, ompA, oomph,
oma87, plpB, sodC
6 Untyped pfhA, Fur, nanB, nanH, ompA, oomph,
oma87, plpB, tbpA
7 Type A ptfA, fimA, hsf-1, hsf-2, toxA, exbD, tonB,
hgbA, hgbB, Fur, nanB, nanH, pmHAS,
ompA, oomph, oma87, plpB, sodA, sodC
8 Type A ptfA, fimA, hsf-1, hsf-2, pfhA, exbB, exbD,
tonB, hgbA, hgbB, Fur, nanB, nanH, pmHAS,
ompA, oomph, oma87, plpB, soda, sodC,
tbpA
9 Type A ptfA, fimA, hsf-1, hsf-2, pfhA, exbB, exbD,
tonB, hgbA, hgbB, Fur, nanB, pmHAS, plpB,
ompA, oomph, oma87, soda, sodC, tbpA
10 Type A ptfA, fimA, exbB, exbD, tonB, hgbA, hgbB,
Fur, nanB, pmHAS, ompA, oma87, plpB,
soda, sodC, tbpA
11 Type D ptfA, fimA, hsf-2, pfhA, exbB, exbD, hgbA,
hgbB, Fur, nanB, nanH, pmHAS, ompA,
oma87, plpB
12 Type A ptfA, fimA, hsf-2, exbB, exbD, tonB, hgbA,
hgbB, pmHAS, oma87, plpB, soda, sodC
13 Type A ptfA, fimA, hsf-1, hsf-2, pfhA, tadD, exbB,
exbD, tonB, hgbA, hgbB, Fur, nanB, ompA,
oomph, oma87, plpB, soda, sodC, tbpA
14 Type A ptfA, fimA, hsf-1, hsf-2, pfhA, tadD, exbB,
exbD, tonB, hgbA, hgbB, Fur, nanB, ompA,
oomph, oma87, plpB, sodA, sodC, tbpA
15 Type A ptfA, fimA, hsf-1, hsf-2, exbB, exbD, tonB,
hgbA, hgbB, Fur, nanB, nanH, ompA,
oomph, oma87, plpB, soda, sodC, tbpA
(Continued)
Table 6 | Continued
Strain ID Capsule type Virulence genes
16 Type D ptfA, fimA, hsf-2, tadD, exbB, exbD, hgbA,
hgbB, Fur, nanB, nanH, pmHAS, ompA,
oomph, oma87, plpB, sodA
17 Type A ptfA, fimA, hsf-2, tadD, exbB, exbD, tonB,
hgbB, Fur, nanB, nanH, ompA, oomph,
oma87, plpB, soda, sodC, tbpA
18 Type A ptfA, fimA, hsf-1, pfhA, toxA, exbB, exbD,
tonB, hgbB, Fur, nanB, nanH, ompA, oomph,
oma87, plpB, soda, sodC, tbpA
19 Type A ptfA, fimA, hsf-1, hsf-2, pfhA, tadD, exbB,
exbD, tonB, hgbB, Fur, nanB, nanH, ompA,
oomph, oma87, plpB, soda, sodC, tbpA
20 Type A ptfA, fimA, hsf-1, hsf-2, toxA, exbB, exbD,
tonB, hgbA, hgbB, Fur, nanB, nanH, ompA,
oomph, oma87, soda, sodC, tbpA
21 Untyped fimA, exbB, hgbA, nanH, ompA, oomph,
plpB
22 Type A ptfA, fimA, hsf-1, hsf-2, pfhA, exbB, exbD,
tonB, hgbA, hgbB, Fur, nanB, nanH, ompA,
oomph, oma87, plpB, soda, sodC, tbpA
23 Type A ptfA, fimA, hsf-2, exbB, exbD, tonB, hgbA,
hgbB, Fur, nanB, nanH, ompA, oomph,
oma87, plpB, soda, sodC, tbpA
24 Type A ptfA, fimA, hsf-2, pfhA, tadD, exbB, exbD,
tonB, hgbA, hgbB, nanB, nanH, ompA,
oomph, oma87, plpB, soda, sodC, tbpA
25 Type A ptfA, fimA, hsf-1, hsf-2, pfhA, tadD, exbB,
tonB, hgbA, hgbB, Fur, nanB, nanH, oomph,
oma87, plpB, soda, sodC, tbpA
26 Type D ptfA, hsf-2, pfhA, exbB, hgbA, hgbB, nanB,
Fur, ompA, oma87, plpB, soda, sodC
27 Type A hsf-1, hsf-2, pfhA, tadD, exbB, exbD, tonB,
hgbA, hgbB, Fur, nanB, nanH, ompA,
oomph, oma87, soda, sodC, tbpA
28 Type A fimA, hsf-1, hsf-2, pfhA, tadD, exbB, exbD,
tonB, hgbA, hgbB, Fur, nanH, oomph,
oma87, soda, sodC, tbpA
29 Type A hsf-1, hsf-2, pfhA, tadD, exbB, exbD, tonB,
hgbA, hgbB, ompA, nanH, oomph, soda,
sodC, tbpA
30 Type A hsf-1, hsf-2, pfhA, tadD, exbB, exbD, tonB,
hgbA, hgbB, nanH, ompA, oomph, oma87,
soda, sodC
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Table 7 | Distribution of VFs according to associated VF genes.
Virulence Overall Pneumonic lung Apparently healthy
genes prevalence isolates lung isolates
(n = 30) (n = 25) (n = 5)
ADHESINS
ptfA 24 (80.0%) 23 (92.0%) 1 (20.0%)
fimA 24 (80.0%) 23 (92.0%) 1 (20.0%)
hsf-1 18 (60.0%) 18 (72.0%) –
hsf-2 23 (76.7%) 23 (92.0%) –
pfhA 18 (60.0%) 15 (60.0%) 3 (60.0%)
tadD 12 (40.0%) 12 (48.0%) –
TOXINS
toxA 3 (10.0%) 3 (12.0%) –
IRON ACQUISITION
exbB 25 (83.3%) 24 (96.0%) 1 (20.0%)
exbD 26 (86.7%) 25 (100.0%) 1 (20.0%)
tonB 25 (83.3%) 24 (96.0%) 1 (20.0%)
hgbA 26 (86.7%) 25 (100.0%) 1 (20.0%)
hgbB 28 (93.3%) 25 (100.0%) 3 (60.0%)
Fur 25 (83.3%) 24 (96.0%) 1 (20.0%)
SIALIDASES nanB
nanB 25 (83.3%) 25 (100.0%) –
nanH 24 (80.0%) 24 (96.0%) –
HYALURONIDASE
pmHAS 10 (33.3%) 10 (40.0%) –
PROTECTINS
ompA 27 (90.0%) 25 (100.0%) 2 (40.0%)
ompH 26 (86.7%) 25 (100.0%) 1 (20.0%)
oma87 27 (90.0%) 25 (100.0%) 2 (40.0%)
plpB 25 (83.3%) 24 (96.0%) 1 (20.0%)
SUPEROXIDE DISMUTASE
sodA 25 (83.3%) 24 (96.0%) 1 (20.0%)
sodC 26 (86.7%) 25 (100.0%) 1 (20.0%)
tbpA 20 (66.7%) 18 (72.0%) 2 (40.0%)
4/46) of this gene in a study conducted on rabbits. Variable fre-
quencies of the genes encoding proteins with different functions,
such as adhesins (fimA, hsf-1, hsf-2, and pfhA), iron acquisi-
tion (exbB, exbD, tonB, hgbA, hgbB, and Fur), sialidases (nanB
and nanH), hyaluronidase (pmHAS), and protectins (oomph
and plpB) were found in the isolates. This finding is similar to
what was reported in previous works which involved ruminants,
porcine, poultry, and rabbits (Ewers et al., 2006; Tang et al., 2009;
Ferreira et al., 2012).
Infections with P. multocida are commonlymanaged by broad-
spectrum antimicrobials (Kehrenberg et al., 2001; Lion et al.,
2006; Brogden et al., 2007). Studies have however reported occur-
rence of resistance to a large number of antimicrobial agents
among P. multocida isolates (Hunt et al., 2001; Davies et al.,
2004; Arashima and Kumasaka, 2005). In the current study
all the P. multocida isolates were susceptible to ciprofloxacin,
co-trimoxazole, doxycycline, enrofloxacin, nitrofurantoin, and
tetracyclines. Similar observations for ciprofloxacin and co-
trimoxazole (Mohamed et al., 2012); and for enrofloxacin,
tetracycline, and doxycycline (Ferreira et al., 2012) have also
Table 8 | Distribution of VFs according to capsule serotypes among
30 bovine isolates of P. multocida.
Virulence Overall capA capD Untyped
genes (n = 30) (n = 23) (n = 5) (n = 2)
ADHESINS
ptfA 24 (80.0%) 19 (82.6%) 5 (100.0%) –
fimA 24 (80.0%) 20 (87.0%) 3 (60.0%) 1 (50.0%)
hsf-1 18 (60.0%) 18 (78.3%) – –
hsf-2 23 (76.7%) 18 (78.3%) 5 (100.0%) –
pfhA 18 (60.0%) 13 (56.5%) 4 (80.0%) 1 (50.0%)
tadD 12 (40.0%) 10 (43.5%) 2 (40.0%) –
TOXINS
toxA 3 (10.0%) 3 (13.0%) – –
IRON ACQUISITION
exbB 25 (83.3%) 19 (82.6%) 5 (100.0%) 1 (50.0%)
exbD 26 (86.7%) 23 (100.0%) 3 (60.0%) –
tonB 25 (83.3%) 23 (100.0%) – 2 (100.0%)
hgbA 26 (86.7%) 20 (87.0%) 5 (100.0%) 1 (50.0%)
hgbB 28 (93.3%) 23 (100.0%) 5 (100.0%) –
Fur 25 (83.3%) 19 (82.6%) 5 (100.0%) 1 (50.0%)
SIALIDASES nanB
nanB 25 (83.3%) 19 (82.6%) 5 (100.0%) 1 (50.0%)
nanH 24 (80.0%) 18 (78.3%) 4 (80.0%) 2 (100.0%)
HYALURONIDASE
pmHAS 10 (33.3%) 8 (34.8%) 2 (40.0%) –
PROTECTINS
ompA 27 (90.0%) 20 (87.0%) 5 (100.0%) 2 (100.0%)
ompH 26 (86.7%) 21 (91.3%) 3 (60.0%) 2 (100.0%)
oma87 27 (90.0%) 21 (91.3%) 5 (100.0%) 1 (50.0%)
plpB 25 (83.3%) 18 (78.3%) 5 (100.0%) 2 (100.0%)
SUPEROXIDE DISMUTASE
sodA 25 (83.3%) 23 (100.0%) 2 (40.0%) –
sodC 26 (86.7%) 23 (100.0%) 3 (60.0%) –
tbpA 20 (66.7%) 18 (78.3%) 1 (20.0%) 1 (50.0%)
been made earlier. These antibiotics can therefore be used
for prevention and treatment of bovine P. multocida infec-
tions in the study area. Unlike other authors who reported
poor (Gutiérrez Martin and Rodríguez Ferri, 1993; Yoshimura
et al., 2001) and moderate (Mohamed et al., 2012) activ-
ity of aminoglycoside antibiotics against P. multocida, in the
present study kanamycin, gentamicin, amikacin, and strepto-
mycin exhibited high activity against the tested isolates. The
frequencies of resistant isolates to other antibiotics varied
greatly as reported by other researchers (Salmon et al., 1995;
Kehrenberg et al., 2001; Yoshimura et al., 2001; Welsh et al.,
2004).
The major limitation in the discussion of the findings of the
current study was large differences in the sample sizes of compar-
ison groups as seen for isolates between isolates from pneumonic
lungs and those from apparently health lungs; and isolates of
different capsular types. This made it difficult to infer on the
observed variations as they could be attributed to chance.
In summary, our results reveal presence of VFs in P. multocida
strains isolated from the lungs of symptomatic and asymptomatic
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Table 9 | Antimicrobial resistance profiles of P. multocida isolates
against 20 antimicrobial agents.
Antimicrobial Resistant Intermediate Susceptible
agent isolates resistant isolates isolates
Ampicillin 10 (33.3%) 11 (36.7%) 9 (30.0%)
Amikacin 0 (0.0%) 1 (3.3%) 29 (96.7%)
Cloramphenicol 0 (0.0%) 0 (0.0%) 29 (96.7%)
Carbenicillin 0 (0.0%) 1 (3.3%) 29 (96.7%)
Ciprofloxacin 0 (0.0%) 0 (0.0%) 30 (100.0%)
Co-trimoxazole 0 (0.0%) 0 (0.0%) 30 (100.0%)
Doxycycline 0 (0.0%) 0 (0.0%) 30 (100.0%)
Enrofloxacin 0 (0.0%) 0 (0.0%) 30 (100.0%)
Gentamicin 0 (0.0%) 1 (3.3%) 29 (96.7%)
Lincomycin 13 (43.3%) 8 (26.7%) 8 (26.7%)
Nitrofurantoin 0 (0.0%) 0 (0.0%) 30 (100.0%)
Oxytetracycline 0 (0.0%) 0 (0.0%) 30 (100.0%)
Penicillin 12 (40.0%) 9 (30.0%) 9 (30.0%)
Rifampin 6 (20.0%) 6 (20.0%) 18 (60.0%)
Streptomycin 5 (16.7%) 0 (0.0%) 25 (83.3%)
Tetracycline 0 (0.0%) 0 (0.0%) 30 (100.0%)
Amoxicillin 3 (10.0%) 3 (10.0%) 24 (80.0%)
Erythromycin 10 (33.3%) 10 (33.3%) 10 (33.3%)
Kanamycin 0 (0.0%) 4 (13.3%) 26 (86.7%)
Florfenicol 5 (16.7%) 6 (20.0%) 19 (63.3%)
slaughter cattle. Frequent detection of the factors among iso-
lates from symptomatic study animals may suggest their role in
pathogenesis of BRD caused by these organisms. Occurrence of
antimicrobial resistance among some isolates is of great concern.
Control strategies for this pathogen, which could include devel-
opment of an effective vaccine, are warranted so as to mitigate
the social and economic consequences attributable to natural
infections with this bacterium. Further, the use of antimicrobial
agents in modern livestock farming need to be controlled so as
to minimize the emergence and eventually spread of resistance
not only in target microbes but also in other important zoonotic
pathogens.
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